- In April 2023, Thermo Fisher Scientific enhanced its operations in France by expanding its capabilities from development to commercial manufacturing. This initiative included the establishment of a 430 square meter (4,600 square feet) research and development facility for pre-clinical, non-GMP operations, alongside expanded good manufacturing practices (GMP) facilities
- In August 2023, Charles River Laboratories International Inc. partnered with Fondazione Telethon to produce high-quality (HQ) plasmids
- In September 2020, Almac Group expanded its portfolio of analytical services by introducing biologics testing solutions. The company announced that these services would now include GMP lot release and stability testing to support customers' drug substance and drug product programs for both innovative biologics and biosimilars.
- In October 2022, MilliporeSigma, the life science division of Merck KGaA, Darmstadt, Germany, inaugurated a commercial facility at its Martillac, France, location. The facility supports its new Millipore CTDMO Services product, enhancing its capabilities in the life sciences sector
- In February 2022, the Center for Breakthrough Medicines (CBM) launched its analytical testing services laboratories, designed to offer comprehensive testing capabilities within the sector. These services aim to address the increasing capacity demands in the cell and gene therapy industry, which faces significant supply constraints
